The International Journal of Pharma Studies follows an open-access publishing model. Published articles are freely accessible to readers, allowing pharmaceutical research and related scholarly work to be read, shared, and used for academic, scientific, and research purposes without a subscription or paywall.

Open Access Publishing

The International Journal of Pharma Studies provides open access to its published scholarly articles and supports the broad dissemination of pharmaceutical research while maintaining continued access to its published academic content.

Articles are made openly accessible immediately upon publication, with no embargo period. Open access applies to articles published through the journal's website and does not exempt authors from applicable Article Processing Charges (APCs).

Creative Commons License

Articles published by the International Journal of Pharma Studies are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License, unless otherwise expressly stated for specific material.

The license permits others to share, redistribute, adapt, and use the licensed work, including commercially, provided that appropriate attribution is given and applicable license conditions are followed. Users must not falsely claim authorship or misrepresent the original article, authors, research findings, or publication.

Copyright Ownership

Authors retain copyright in their original work in accordance with the applicable Author Rights and Licensing terms of the International Journal of Pharma Studies.

Publication in the journal does not transfer copyright ownership to the journal. The journal receives the rights necessary to publish, distribute, make the article openly accessible, preserve the published record, and maintain the official Version of Record, as applicable.

Reuse of Published Articles

Published articles may be reused in accordance with the applicable licensing terms. Appropriate credit should be given to the original author(s) and publication, together with the article's DOI or official publication link where available.

For pharmaceutical research, reused material may include scientific findings, drug-related research, experimental methods, analytical data, tables, and figures, subject to the applicable license and any relevant third-party restrictions.

Author Sharing

Authors may share the published version of their work through appropriate scholarly channels, including institutional repositories, academic profiles, research-sharing platforms, and personal academic websites, in accordance with their applicable rights and licensing terms.

Authors are encouraged to retain the original citation, DOI, journal name, and publication information when sharing their work. When sharing pharmaceutical or clinical research, authors must also ensure that any patient-related information, confidential data, or restricted third-party material is handled in accordance with applicable ethical, privacy, and legal requirements.

Long-Term Access and Preservation

The International Journal of Pharma Studies aims to maintain continued access to its published scholarly content. The journal makes reasonable efforts to preserve published article files, associated metadata, persistent identifiers, and the official Version of Record.

Where an appropriate digital preservation service is implemented, it may be used to support the long-term preservation of the journal's published scholarly content. Such preservation arrangements are intended to support continued access to the scholarly record in the event of disruption to the journal's primary website or publishing platform, subject to the technical and operational availability of the relevant service.

Access to Published Content

Published articles in the International Journal of Pharma Studies are intended to remain accessible through the official journal website.

Where persistent identifiers such as DOIs are assigned, the journal makes reasonable efforts to maintain the associated publication information and article links. Updates by external indexing, abstracting, repository, or discovery services are dependent on the policies and systems of those third parties.

Related Policies

This policy should be read together with the relevant policies of the International Journal of Pharma Studies, including:

The International Journal of Pharma Studies may review and update this policy as its publishing practices and relevant scholarly publishing standards develop.